Can Advanced Therapies Improve Outcomes for PFIC Type 2 Patients?

добавлена новая статья Art

2026-04-09 07:55:12

"In-Depth Study on Executive Summary Progressive Familial Intrahepatic Cholestasis Type 2 Treatment Market Size and Share CAGR Value The global progressive familial intrahepatic cholestasis type 2 treatment market size was valued at USD 154.80 million in 2025 and is expected to reach USD 248.59 million by 2033, at a CAGR of 6.10% during the forecast...

0 Комментарии 0 Поделились 19 Просмотры 0 предпросмотр